Buy: $ 0,27
Sell: $ ? OPEN
Profit: +30%
Vol.: 400K
All-Time-Low: $0,25
Shares Outstanding: 38.04 Mill.
Market Cap (last close) 12.28 Mill.
NEWS:
NEWTOWN, Pa., April 22, 2020 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX: HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced the appointment of Jeffrey S. Mathiesen, CPA, to its Board of Directors, effective as of June 9, 2020. Upon his appointment, Mr. Mathiesen will serve as Chair of the Company's Audit Committee.
S F
Sell: $ ? OPEN
Profit: +30%
Vol.: 400K
All-Time-Low: $0,25
Shares Outstanding: 38.04 Mill.
Market Cap (last close) 12.28 Mill.
NEWS:
NEWTOWN, Pa., April 22, 2020 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX: HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced the appointment of Jeffrey S. Mathiesen, CPA, to its Board of Directors, effective as of June 9, 2020. Upon his appointment, Mr. Mathiesen will serve as Chair of the Company's Audit Committee.
S F
